We recently compiled a list of the 10 Biggest Losers of This Week. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against the other stocks.

Wall Street's main indices all finished in the green during a shortened trading session this week, yet 10 companies--mainly technology stocks-- still booked significant losses in their valuations. Let's take a look at the extent of each company's losses and the potential factors that could have dampened investor sentiment.

To come up with the biggest losers this week, we considered only the stocks that have at least $2 billion in market capitalization and $5 million in daily trading volume.

A close-up of a laboratory technician in a laboratory, measuring a newly developed biopharmaceutical drug.

Geron Corp. (NASDAQ:GERN)

Geron Corp. (GERN) saw its shares drop by 4.3 percent to $3.34 from $3.49 apiece. Geron (GERN) is a biopharmaceutical company. Geron recently announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of its drug Rytelo for treating specific types of myelodysplastic syndromes. The European Commission will now review this recommendation, with a final decision on market authorization expected in the coming months.

According to analysts, the company continues to ingest news of the company’s earnings performance, with the firm still booking a net loss in the third quarter of the year—$26.4 million, albeit lower than the $44.8 million reported in the same period last year.

However, the first nine months of the year saw a higher net loss of $149.2 million as compared with the $132.2 million registered year-on-year.

Overall GERN ranks 5th on our list of the biggest losers of this week. While we acknowledge the potential of GERN as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than GERN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

 

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock

 

Disclosure: None. This article is originally published at Insider Monkey.